Pulmonary embolism in adolescent with COVID-19 during aromatase inhibitor therapy

Pediatr Pulmonol. 2022 Jul;57(7):1789-1791. doi: 10.1002/ppul.25944. Epub 2022 May 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Aromatase Inhibitors / adverse effects
  • COVID-19*
  • Humans
  • Pulmonary Embolism* / diagnostic imaging
  • Pulmonary Embolism* / drug therapy
  • SARS-CoV-2

Substances

  • Aromatase Inhibitors